Skip to main content

Table 3 Results of consistency analysis in the two study treatment groups

From: Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan

 

Frovatriptan

Rizatriptan

p

Pain relief episodes at 2 h

19 (76)

20 (74)

NS

Pain free episodes at 2 h

11 (73)

16 (80)

NS

Pain relief episodes at 24 h

28 (80)

25 (81)

NS

Pain free episodes at 24 h

23 (70)

23 (64)

NS

Recurrent episodes at 24 h

3 (60)

16 (84)

NS

  1. Consistency of was response was defined as responders in 2 and 3 out of 3 attacks. Data are reported as absolute (n) and relative (%) frequency. p refers to the statistical significance of the difference between the two study drugs